In a new position paper published in today’s edition of the Weekly Epidemiological Record, WHO recommends that countries should consider introduction of the dengue vaccine CYD-TDV or Dengvaxia® only in geographic settings where epidemiological data indicate a high burden of disease.
New data on global immunization coverage show that 65% of the world’s children received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccines in 2015, a coverage level that has been sustained above 86% since 2010.
The number of children who did not receive routine vaccinations dropped to an estimated 19.4 million, down from 33.8 million in 2000.
The Gavi Vaccine Alliance has announced that it will support a WHO-coordinated pilot programme for the malaria vaccine RTS,S/AS01 (RTS,S). “This decision by the Gavi Board truly responds to countries' demands” says Dr Flavia Bustreo, Assistant Director-General at WHO and vice-chair of the Gavi board. “We trust that others will be forthcoming so we can take full advantage of this chance to improve malaria control and reduce child mortality in Africa.”
The WHO Strategic Advisory Group of Experts on Immunization (SAGE) found that one fifth of the regular dose of yellow fever vaccine could be used to control an outbreak in case of vaccine shortages. In the current yellow fever outbreak, almost 18 million doses of yellow fever vaccine have been distributed in emergency vaccination campaigns in Angola, Democratic Republic of the Congo, and Uganda.